Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-01-10
2006-01-10
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600
Reexamination Certificate
active
06984628
ABSTRACT:
This invention relates to compositions comprising trefoil family factor peptides which are useful in preventing or treating dry eye by topical administration of the composition to eye of the patient. One aspect of this invention relates to topical ophthalmic compositions comprising a trefoil factor family peptide, and preferably, a mucoadhesive component, as described herein. Another aspect of this invention relates to the use of these compositions to treat or prevent dry eye in a patient.
REFERENCES:
patent: 4839342 (1989-06-01), Kaswan
patent: 5474979 (1995-12-01), Ding et al.
patent: 5620921 (1997-04-01), Sullivan
patent: 5652209 (1997-07-01), Pflugfelder et al.
patent: 5688765 (1997-11-01), Sullivan
patent: 5900407 (1999-05-01), Yerxa et al.
patent: 5958912 (1999-09-01), Sullivan
patent: 5981607 (1999-11-01), Ding et al.
patent: 6056950 (2000-05-01), Saettone et al.
patent: 6063755 (2000-05-01), Podolsky
patent: 6107289 (2000-08-01), Sullivan
patent: 6153607 (2000-11-01), Pflugfelder et al.
patent: 6221840 (2001-04-01), Podolsky
patent: 6277855 (2001-08-01), Yerxa
patent: 6316218 (2001-11-01), Podolsky
patent: 6319908 (2001-11-01), Yerxa et al.
patent: 6323187 (2001-11-01), Yerxa et al.
patent: 6331529 (2001-12-01), Yerxa et al.
patent: 6348508 (2002-02-01), Denick, Jr. et al.
patent: 6348589 (2002-02-01), Pendergast et al.
patent: 6432934 (2002-08-01), Gilbard
patent: 6436910 (2002-08-01), Yerxa et al.
patent: 6455583 (2002-09-01), Pflugfelder et al.
patent: 6525018 (2003-02-01), Podolsky
patent: 6548658 (2003-04-01), Yerxa
patent: 6555675 (2003-04-01), Rideout et al.
patent: 6585987 (2003-07-01), Fransoni
patent: 2002/0037842 (2002-03-01), Leahy et al.
patent: 2002/0119104 (2002-08-01), Rosenthal et al.
patent: 2002/0151472 (2002-10-01), Thim et al.
patent: 2003/0032585 (2003-02-01), Thim et al.
patent: 2003/0153496 (2003-08-01), Thim et al.
patent: 0473159 (1992-03-01), None
patent: 0590655 (1994-04-01), None
patent: WO 02/46226 (2002-06-01), None
patent: WO 02/085402 (2002-10-01), None
patent: WO 02/102399 (2002-12-01), None
patent: WO 02/102403 (2002-12-01), None
Allen, et al., The mucus barrier, its role in gastroduodenal mucosal protection,J. Clin Gastroenterol, 1998; 10 (Suppl1): S93-S98;.
Babyatsky, M.W., et al.,Oral trefoil peptides protect against ethanol-and indomethacin-induced gastric injury in rats,Gastroenterology, 1996, vol. 110, pp. 489-497.
Carr, M. D., et al., Solution Structure of Trefoil factor family proteins,Univ. of Kent, 3 pgs, www.biochem.ucl.ac.uk, (Feb. 13, 2003).
Corfield, A.P., et al., Ocular mucins: purification, metabolism and functions,Progress in Retinal and Eye Research, vol. 16, No. 4, pp 627-656, 1997.
Danjo, Y., et al., Alteration of mucin in human conjunctival epihtelia in dry eye,Invest Ophthalmol Vis Sci, 1998, V 39, pp 2602-09.
Dignass, A., et al., Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway,J. Clin. Invest.94, 376-383, (Jul. 1994).
Gipson, I.K., et al., Mucin genes expressed by the ocular surface epithelium,Progress in Retinal and eye research, vol. 16, No. 1, pp. 81-98, 1997.
Good, R.J., Surface free energy of solids and liquids: thermodynamics, molecular forces, and structures,J. Colloid Interface Sci.; 1977, 59:398-419.
Goke,M., et al., Trefoil peptides promote restitution of wounded corneal epithelial cells,Experimental Cell Research, 2001, V. 264, pp. 337-344.
Hauser, F., et al., Hp1.b, A human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus,Proc Natl Acad Sci USA, 1993, V. 90, pp. 6961-6965.
Jagla, W., et al., Localization of TFF3 peptide to porcine conjunctival goblet cells,Cell tissue res(1999) 296:525-530.
Langer, G., Secretory peptides TFF1 and TFF3 synthesized in human conjunctival goblet cells,Invest Ophthalmol Vis Sci, 1999, V. 40, pp 2220-2224.
Langer, G., Et Al., TFF Peptides, New Mucus-Associated Secretory Products Of The Conjunctiva,Opthalmologe, 2001-98:976-979.
Ligumsky, et al., Sucralfate protection against gastrointestinal damage: possible role of prostanoids,Isr J Med Sci1986; 22:801-806.
Paulsen, F.P., et al., TFF peptides in the human efferent tear ducts,Invest Ophthalmol Vis Sci, 2002, V 43, pp. 3359-3364.
Playford, R.J., Trefoil peptides: what are they and what do they do?,Journal of the Royal College of Physicians of London, vol. 31, pp. 37-40, (Jan./Feb. 1997).
Rachmilewitz, D., Trefoil peptides: a novel modality to prevent gastric injury?,Gastroenterology, vol. 110, No. 2, pp. 632-635, (Feb. 1996).
Tabor, et al., Surface Forces and Surface Interactions,J. Colloid Interface Sci, 1977, 58:2-13.
Tran, C.P., et al., Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis,OVID: Tran: Gut, vol. 44(5) May 1999, 636-642.
Uebermuth, C., Mucins of the eye,Ophthalmologe, 1999—96:563-569.
Wong, W.M., et al., Trefoil Peptides,Gut, vol. 44(6) Jun. 1999, 890-895.
Williams, et al., Trefoil factor family domain peptides,Virchows arch, 1997 431:299-304.
Wright, N.A., Interaction of trefoil family factors with mucins: clues to their mechanism of action?,Gut, vol. 48(3) Mar. 2001, pp 293-294.
Teraing and Dry Eyes,Ocular Times, Eye News and Information; www.geocities.com/ocular—times/tearing.html, Feb. 14, 2003, 4 pgs.
Bakhit Peter G.
Graham Richard
Olejnik Orest
Allergan Inc.
Baran Robert J.
Johnson Brent A.
Russel Jeffrey Edwin
Voet Martin A.
LandOfFree
Ophthalmic compositions comprising trefoil factor family... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic compositions comprising trefoil factor family..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions comprising trefoil factor family... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3596075